Chronic Myeloid Leukemia: A Review
JAMA Clinical Reviews
00:00
Criteria for Stem Cell Transplant and Discontinuation of Therapy
This chapter explores the evolving criteria for candidates eligible for hematopoietic stem cell transplants, noting a decrease in their use in the USA due to the success of new therapies. It highlights key considerations for patients with chronic myeloid leukemia (CML) and the potential for safely discontinuing tyrosine kinase inhibitors under certain conditions.
Transcript
Play full episode
